Self-administered psychosocial intervention delivered via smartphone.
Self-administered psychosocial intervention delivered via smartphone.: The treatment includes a smartphone-based psychosocial program designed to improve the quality of life of adolescents with chronic pain.
Study summary
Research has shown that the prevalence of chronic pain in adolescents is high and increasing. These young people report significant changes in both their physical and psychological functioning. Currently, psychosocial treatments enjoy strong empirical support and are crucial to maintaining and improving the quality of life of adolescents suffering from chronic pain. However, the availability of these evidence-based interventions is insufficient to meet the high demand, especially outside of large cities. The aim of this project is to develop a digital treatment that helps improve the quality of life of adolescents with chronic pain and complementary websites for their parents and teachers.
Eligibility
Sex
ALL
Min age
12 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria:
* 12-18 years old,
* Having a non-oncology secondary chronic pain problem,
* Having internet access,
* A parent willing to participate in the study,
* Providing informed consent/assent.
Exclusion Criteria:
* Cognitive or language problems
Primary outcome measure(s)
Pain intensity — baseline, 8 weeks, 3 months follow-up Refers to the severity of pain an individual experiences, measured on a scale (0-10)
Pain interference — baseline, 8 weeks, 3 months follow-up Refers to the extent to which pain affects an individual's daily life and functioning. Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Pain Interference will be used (0-32; 0=no interference, 32=intense interference).
Global perception of change after treatment — 8 weeks, 3 months follow-up refers to an individual's overall assessment of how their condition has improved or worsened following a treatment, measured on a scale (0-10).
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.